Floatz logo

et140203 t cells

HEMNOS

Eureka Therapeutics Inc.Cell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the HEMNOS cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

et140203 t cells is also rated in:

liver cancerDormant
CCC
Indicative ·
48 / 100
View asset →
hepatoblastomaDormant
CC
Indicative ·
47 / 100
View asset →
liver and intrahepatic bile duct neoplasmDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →